CTOs on the Move

Telco Intercontinental Inc

www.telcointercon.com

 
Telco Intercontinental Corporation is a trading company and manufacturer of electronic products of Motors, Monitors, Interconnections and Public Telephony. Our objective is to be a leader in the market thanks to our commitment to the Quality and
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

CMK Design

CMK Design is a Lebanon, PA-based company in the Business Services sector.

information enterprises inc

information enterprises inc is a Waltham, MA-based company in the Business Services sector.

Computer Insights

Computer Insights, Inc. is a Bloomingdale, IL-based company in the Business Services sector.

Onward

Ship faster for less with an entire network of carriers looking to fill their truck. We match your large goods onto trucks that are already heading towards your recipient.

Oculis

Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.